Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37

Rens Peeters, Jorge Cuenca‐Escalona, Esther A. Zaal, +13

Nature Communications

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion

Camille M. Le Gall, Anna Cammarata, Lukas de Haas, +11

Journal for ImmunoTherapy of Cancer

PGE2‐EP4 signaling steers cDC2 maturation toward the induction of suppressive T‐cell responses

Jorge Cuenca‐Escalona, Georgina Flórez‐Grau, Koen van den Dries, +2

European Journal of Immunology

cDC2 plasticity and acquisition of a DC3‐like phenotype mediated by IL‐6 and PGE2 in a patient‐derived colorectal cancer organoids model

Beatriz Subtil, Iris A.E. van der Hoorn, Jorge Cuenca‐Escalona, +11

European Journal of Immunology

Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways

Glenn F. van Wigcheren, Jorge Cuenca‐Escalona, Suzan Stelloo, +12

Journal of Biological Chemistry

EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells

Jorge Cuenca‐Escalona, Beatriz Subtil, A. García-Pérez, +3

Frontiers in Immunology

EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s

Jorge Cuenca‐Escalona, Johanna Bödder, Beatriz Subtil, +7

Journal of Leukocyte Biology